Liver transplantation of patients with cryptogenic cirrhosis: Clinical characteristics and outcome

References

• Sutedja DS, Gow PJ, Hubscher SG, Elias E. Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy. Transplant Proc 2004;36:2334–7.
   PubMed Web of Science ®Google Scholar
• Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, Cryptogenic cirrhosis: Clinicopathologic findings at and after liver ransplantation. Hum Pathol 2002;33:1098–104.
   PubMed Web of Science ®Google Scholar
• Duclos-Valée J-C, Yilmaz F, Johanet C, Roque-Afonso A-M, Gigou M, Trichet C, Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis? Clin Transpl 2005;19:591–9.
   Google Scholar
• Contos MJ, Cales W, Sterling RK, Luketic VA, Mitchell L, Shiffman ML, Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 2001;7:363–73.
   PubMed Web of Science ®Google Scholar
• Heringlake S, Schütte A, Flemming P, Schmiegel W, Manns MP, Tillmann HL. Presumed cryptogenic liver disease in Germany: high prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology. Z Gastroenterol 2009;47:417–23.
   PubMedGoogle Scholar
• Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis; a case control study. Hepatology 2000;32:689–92.
   PubMed Web of Science ®Google Scholar
• Tellez-Avila FI, Sanchez-Avila F, García-Saenz-de-Sicilia M, Chavez-Tapia NC, Franco-Guzman AM, Lopez-Arce G, Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis. World J Gastroenterol 2008;30:4771–5.
   Google Scholar
• Henegan MA, Zolfino T, Muiesan P, Portmann BC, Rela M, Heaton ND, An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis. Liver Transplant 2003;9:921–8.
   PubMedGoogle Scholar
• Maheshwari A, Thuluvath PJ. Cryptogenic cirrhosis and NAFLD: Are they related? Am J Gastroenterol 2006;101:664–8.
   PubMed Web of Science ®Google Scholar
• Charlton MR, Kondo M, Roberts SK, Steers JL, Krom RA, Wiesner RH. Liver transplantation for cryptogenic cirrhosis. Liver Transplant Surg 1997;3:359–64.
   PubMedGoogle Scholar
• Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier M-H, Survival, liver failure and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002;35:1485–93.
   PubMed Web of Science ®Google Scholar
• Giannini EG, Marabotto E, Savarino V, Trevisani F, Di Nolfo MA, Del Poggio P, Hepatocellular carcinoma in patients with cryptogenic cirrhosis. Clin Gastroent Hepatol 2009;7:580–5.
   PubMedGoogle Scholar
• Malik SM, deVera ME, Fontes P, Shaikh O, Ahmad J. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant 2009;9:782–93.
   PubMed Web of Science ®Google Scholar
• Sanjeevi A, Lyden E, Sunderman B, Weseman R, Ashwathnarayan R, Mukherjee S. Outcomes of liver transplantation for cryptogenic cirrhosis: A single center study of 71 patients. Transplant Proc 2003;35:2977–80.
   PubMedGoogle Scholar
• Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004;24:3–20.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Freese DK, American Association for the Study of Liver Disease. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479–97.
   PubMed Web of Science ®Google Scholar
• Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356–62.
   PubMed Web of Science ®Google Scholar
• Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664–9.
   PubMed Web of Science ®Google Scholar
• Caldwell SH, Crespo DM. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol 2004;40:578–84.
   PubMed Web of Science ®Google Scholar
• Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Expanding the natural history of non-alcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134–40.
   PubMed Web of Science ®Google Scholar
• Clark JM, Diehl AM. Non-alcoholic fatty liver disease: An unrecognized cause of cryptogenic cirrhosis. JAMA 2003;289:3000–4.
   PubMed Web of Science ®Google Scholar
• Mulhall BP, Ong J, Younossi ZM. Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol 2002;17:1136–43.
   PubMedGoogle Scholar
• Ekstedt M, Franzén LR, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Long term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865–73.
   PubMed Web of Science ®Google Scholar
• Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrosis? Hepatology 2002;36:150–5.
   PubMed Web of Science ®Google Scholar
• Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Gina Boffo G, Nutrition and survival in patients with liver cirrhosis. Nutrition 2001;17:445–50.
   PubMed Web of Science ®Google Scholar
• Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, Long term outcome of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 2003;38:420–7.
   PubMed Web of Science ®Google Scholar